What is the recommended initial management for a 45-year-old woman with left lower extremity cellulitis?

Management of Left Lower Limb Cellulitis in a 45-Year-Old Woman

First-Line Antibiotic Therapy

Start cephalexin 500 mg orally every 6 hours for 5 days; this beta-lactam monotherapy achieves 96% clinical success in typical cellulitis and is the standard of care. 1

• Alternative oral beta-lactams include dicloxacillin 250–500 mg every 6 hours or amoxicillin 500 mg three times daily, all providing excellent coverage against beta-hemolytic streptococci (especially Streptococcus pyogenes) and methicillin-sensitive Staphylococcus aureus, the pathogens responsible for the vast majority of cellulitis cases. 1, 2, 3

• Treatment duration is exactly 5 days if warmth, tenderness, and erythema are improving and the patient is afebrile; extend only if these signs have not improved within this timeframe. 1, 4 High-quality randomized controlled trial evidence confirms that 5-day courses are as effective as 10-day courses for uncomplicated cellulitis. 1

When to Add MRSA Coverage (and When NOT To)

Do NOT add MRSA-active antibiotics routinely—MRSA is an uncommon cause of typical non-purulent cellulitis even in high-prevalence settings, and adding coverage without specific risk factors represents overtreatment. 1, 3, 5

Add MRSA coverage ONLY if any of the following risk factors are present: 1, 2

• Penetrating trauma or injection drug use
• Visible purulent drainage or exudate at the infection site
• Known MRSA colonization or prior MRSA infection
• Systemic inflammatory response syndrome (fever >38°C, heart rate >90 bpm, respiratory rate >24 breaths/min)
• Failure to respond to beta-lactam therapy after 48–72 hours

If MRSA coverage is indicated, choose one of these regimens: 1

• Clindamycin 300–450 mg orally every 6 hours (single-agent coverage for both streptococci and MRSA, but use only if local MRSA clindamycin resistance is <10%)
• Trimethoprim-sulfamethoxazole 1–2 double-strength tablets twice daily PLUS a beta-lactam (e.g., cephalexin or amoxicillin)
• Doxycycline 100 mg orally twice daily PLUS a beta-lactam

Critical pitfall: Never use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for typical cellulitis—they lack reliable activity against beta-hemolytic streptococci, the predominant pathogens. 1

Hospitalization Criteria

Admit the patient if any of the following are present: 1, 6

• Systemic inflammatory response syndrome (fever, tachycardia, hypotension, altered mental status)
• Signs of deeper or necrotizing infection (severe pain out of proportion to examination, skin anesthesia, rapid progression over hours, "wooden-hard" subcutaneous tissue, violaceous bullae, or palpable gas)
• Severe immunocompromise or neutropenia
• Failure of outpatient therapy after 24–48 hours

For hospitalized patients requiring IV therapy: 1

• Cefazolin 1–2 g IV every 8 hours is the preferred IV beta-lactam for uncomplicated cellulitis
• For severe cellulitis with systemic toxicity or suspected necrotizing infection: vancomycin 15–20 mg/kg IV every 8–12 hours PLUS piperacillin-tazobactam 3.375–4.5 g IV every 6 hours

Essential Adjunctive Measures

Elevate the affected leg above heart level for at least 30 minutes three times daily—this promotes gravity drainage of edema and inflammatory substances, hastening clinical improvement. 1, 4

Examine interdigital toe spaces carefully for tinea pedis, fissuring, scaling, or maceration; treating these conditions eradicates colonization and reduces recurrent infection risk. 1, 7

Address predisposing conditions including venous insufficiency, lymphedema, chronic edema, obesity, and eczema to minimize recurrence. 1, 7 For patients with 3–4 episodes per year despite treating these factors, consider prophylactic antibiotics such as oral penicillin V 250 mg twice daily. 1

Monitoring and Follow-Up

Reassess within 24–48 hours to confirm clinical improvement; oral regimens have reported failure rates around 21% if no response is seen. 1 If no improvement after 48–72 hours of appropriate therapy, consider resistant organisms (MRSA), undrained abscess, deeper infection, or alternative diagnoses such as venous stasis dermatitis or deep vein thrombosis. 1, 3, 6

Do not automatically extend therapy to 7–10 days based on residual erythema alone—some inflammation persists even after bacterial eradication. Extend only if warmth, tenderness, or erythema have not improved after the initial 5-day course. 1

Common Pitfalls to Avoid

• Do not obtain blood cultures for typical uncomplicated cellulitis—they are positive in only ~5% of cases and represent unnecessary resource utilization. 1, 2
• Do not delay surgical consultation when any necrotizing-infection warning signs are present (severe pain out of proportion, rapid progression, bullae, gas, or necrosis)—prompt debridement is essential. 1
• Do not add MRSA coverage reflexively for typical non-purulent cellulitis without the specified risk factors, as this overtreats ~96% of cases and drives antimicrobial resistance. 1, 5